# Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects

> **NCT04438720** · PHASE1 · UNKNOWN · sponsor: **Cao Yu** · enrollment: 60 (estimated)

## Conditions studied

- Therapeutic Equivalency

## Interventions

- **DRUG:** Extended Release Nifedipine Tablets 30 mg
- **DRUG:** Extended Release Nifedipine Tablets 30 mg (Adalat® GITS)

## Key facts

- **NCT ID:** NCT04438720
- **Lead sponsor:** Cao Yu
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-25
- **Primary completion:** 2020-09-09
- **Final completion:** 2020-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438720, "Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04438720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*